Skip to main content
Premium Trial:

Request an Annual Quote

Matt Posard

GenePeeks has appointed Matt Posard as president and chief commercial officer.

Posard will lead commercialization of the firm's genetic disease risk analysis products.

He most recently led Trovagene's commercial operations as executive VP and CCO. Prior to that, he spent nine years at Illumina, serving in senior marketing, sales, and other commercial roles, as well as time with Alere and Hologic.

Posard sits on the board of directors of several biotech firms such as Slip Chip and Omicia.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.